{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:39:33Z","timestamp":1791005973911,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ankylosing spondylitis (AS) is most common in adolescents and the ultimate result is disability, which places a huge burden on patients and society. Therefore, the key to improve the prognosis of AS is the early diagnosis of hip injury. To examine if AS patients whose hip pain is either absent or minimal might already have observable MRI and X-ray hip changes. Clinical and imaging hip data were systematically analyzed in 200 healthy controls (HC) and 300 AS with varying degrees of hip pain. Forty-four patients with early hip osteoarthritis (OA) served as positive imaging controls. In MRI images, BME lesions in the STIR sequence were much more frequent in AS (62%) compared to HC (2%) (p &amp;lt; 0.0001). Most importantly, 42% of AS with no or minimal hip pain had one or more MRI lesions. This was much more frequent compared to the 2% in HC (p &amp;lt; 0.05). These lesions in AS were observed singly or in combination in the trochanters (8%), femoral heads (12%), and acetabula (13%). Parallel finding that X-ray changes were present in patients with minimal or no hip pain was also observed with X-ray. Based on the normal hip width of HC, joint space narrowing was observed in 94.3% of the entire AS cohort, and importantly 56.7% of AS patients with no or mild hip pain. In these latter patients, functional activities of the hips such as walking were normal. At least 40% of AS patients with minimal or no hip pain might already show MRI and X-ray changes.<\/jats:p>","DOI":"10.3389\/fimmu.2021.668969","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T05:52:17Z","timestamp":1616565137000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A Comprehensive Assessment of Hip Damage in Ankylosing Spondylitis, Especially Early Features"],"prefix":"10.3389","volume":"12","author":[{"given":"Qing","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22831","article-title":"Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/kep298","article-title":"Hip involvement in ankylosing spondylitis: what is the verdict","volume":"49","author":"Baraliakos","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B5","article-title":"Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression","volume":"28","author":"Brophy","year":"2001","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"D4524","DOI":"10.1002\/14651858.CD004524.pub4","article-title":"Methotrexate for ankylosing spondylitis","volume":"2013","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis 2017"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.229","article-title":"Characteristics of hip involvement in patients with ankylosing spondylitis in Korea","volume":"32","author":"Jeong","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem166","article-title":"Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab","volume":"46","author":"Baraliakos","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/kep174","article-title":"Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery","volume":"49","author":"Vander","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283620e04","article-title":"Hip disease in ankylosing spondylitis","volume":"25","author":"Vander","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072512","article-title":"Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort","volume":"67","author":"Gensler","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041137","article-title":"ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0883-5403(00)91155-0","article-title":"Primary total hip arthroplasty in patients with ankylosing spondylitis","volume":"15","author":"Tang","year":"2000","journal-title":"J Arthroplasty"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01477.x","article-title":"Total hip arthroplasty in patients with chronic autoimmune inflammatory arthroplasties","volume":"13","author":"Chong","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"B18","article-title":"Prevalence and characteristics of hip involvement in spondyloarthritis: a single-centre observational study of 275 patients","volume":"30","author":"Burki","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.07.008","article-title":"Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis","volume":"40","author":"Chen","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2013.03.020","article-title":"The application of MR imaging in the detection of hip involvement in patients with ankylosing spondylitis","volume":"82","author":"Huang","year":"2013","journal-title":"Eur J Radiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04466-9","article-title":"Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: an observational, retrospective cohort study","volume":"38","author":"Huang","year":"2019","journal-title":"Clin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.668969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T05:52:22Z","timestamp":1616565142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.668969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2021.668969"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.668969","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"article-number":"668969"}}